Skip to main content
. 2020 Jun 8;45(7):619–625. doi: 10.1007/s00059-020-04951-x

Fig. 1.

Fig. 1

Illustration of various cancer therapeutics with known cardiovascular side effects. Green, conventional cancer therapy; blue, targeted cancer therapy. BRAF mutated rapidly accelerated fibrosarcoma kinase B, EGFR endothelial growth factor receptor, HER2 human epidermal growth factor receptor 2, MEK mitogen-activated protein kinase kinase, VEGF vascular endothelial growth factor receptor